Cerebral Artery Occlusion Clinical Trial
Official title:
Evaluation of Clinical Results of Treatment of Cerebral Artery Occlusion by Mechanical Thrombectomy, in the Acute Phase of Stroke
The Ischemic Brain Vascular Accident (CVA) is a major public health issue. An Early and
appropriate charging anyone with stroke is essential to reduce mortality, reduce dependency
and promote recovery of autonomy. Intravenous fibrinolysis in patients with cerebral
infarction (NINDS 1995), is reserved for a small proportion of highly selected patients. It
therefore remains a significant therapeutic challenge, especially for patients with
against-indications to fibrinolysis or in whom there is no immediate benefit. For twenty
years of mechanical devices have been developed to remove, as quickly as possible, the cause
of intracranial arterial occlusion and allow restoration of blood flow before brain damage
is irreversible.
NTF The protocol is part of the evaluation process of our clinical practices recommended by
the National Health Authority (HAS), in the specific context of mechanical thrombectomy
performed in French centers of interventional neuroradiology working with neurovascular
units (A V).
n/a
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05342714 -
Remote Ischemic Conditioning for Chronic Cerebral Artery Occlusion
|
N/A |